Life Technologies Launches Alliance to Evaluate Whole-Genome Sequencing for Guiding Cancer Treatment

The alliance is primarily funded by Life Technologies for now and will use the company's SOLiD 4 sequencing platform. Other founding partners include the Fox Chase Cancer Center, Scripps Genomic Medicine, and the Translational Genomics Research Institute.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.